The Cardiovascular Effects of Peroxisome Proliferator-activated Receptor Agonists Reply

被引：0
|
作者：
Friedland, Sayuri [1 ]
Filion, Kristian B. [1 ,2 ]
Eisenberg, Mark J. [1 ,3 ]
机构：
[1] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Lady Davis Res Inst, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Med, Div Clin Epidemiol, Montreal, PQ, Canada
[3] McGill Univ, Jewish Gen Hosp, Div Cardiol, Montreal, PQ H3T 1E2, Canada
来源：
AMERICAN JOURNAL OF MEDICINE | 2013年 / 126卷 / 03期
关键词：
RISK;
D O I：
10.1016/j.amjmed.2012.10.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E13 / E13
页数：1
相关论文
共 50 条
  • [41] Effects of peroxisome proliferator-activated receptor-γ agonists on central nervous system inflammation
    Kielian, T
    Drew, PD
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 71 (03) : 315 - 325
  • [42] Kojyl cinnamate esters are peroxisome proliferator-activated receptor α/γ dual agonists
    Kim, Sae On
    Han, Yujia
    Ahn, Sungjin
    An, Seungchan
    Shin, Jeayoung C.
    Choi, Hyunjung
    Kim, Hyoung-June
    Park, Nok Hyun
    Kim, Yong-Jin
    Jin, Sun Hee
    Rho, Ho Sik
    Noh, Minsoo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (21) : 5654 - 5663
  • [43] Peroxisome Proliferator-Activated Receptor Agonists Inhibit Inflammatory Edema and Hyperalgesia
    Bradley K. Taylor
    Niren Dadia
    Carolyn B. Yang
    Sendhil Krishnan
    Mostafa Badr
    Inflammation, 2002, 26 : 121 - 127
  • [44] Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney
    Speeckaert, Marijn M.
    Vanfraechem, Celine
    Speeckaert, Reinhart
    Delanghe, Joris R.
    AGEING RESEARCH REVIEWS, 2014, 14 : 1 - 18
  • [45] Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders
    Sagheddu, Claudia
    Melis, Miriam
    Muntoni, Anna Lisa
    Pistis, Marco
    PHARMACEUTICALS, 2021, 14 (10)
  • [46] Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?
    Blaschke, F
    Bruemmer, D
    Law, RE
    CLINICAL CARDIOLOGY, 2004, 27 (07) : 3 - 10
  • [47] Aging and enhanced hepatocarcinogenicity by peroxisome proliferator-activated receptor alpha agonists
    Youssef, JA
    Badr, MZ
    AGEING RESEARCH REVIEWS, 2005, 4 (01) : 103 - 118
  • [48] Peroxisome proliferator-activated receptor agonists inhibit inflammatory edema and hyperalgesia
    Taylor, BK
    Dadia, N
    Yang, CB
    Krishnan, S
    Badr, M
    INFLAMMATION, 2002, 26 (03) : 121 - 127
  • [49] The discovery of novel isoflavone pan peroxisome proliferator-activated receptor agonists
    Matin, Azadeh
    Doddareddy, Munikumar Reddy
    Gavande, Navnath
    Nammi, Srinivas
    Groundwater, Paul W.
    Roubin, Rebecca H.
    Hibbs, David E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (03) : 766 - 778
  • [50] Role of NSAIDs and peroxisome proliferator-activated receptor γ-agonists on APP processing
    Sastre, M
    Freihoff, D
    Klockgether, T
    Heneka, MT
    Landreth, G
    Gavrilyuk, V
    Feinstein, DL
    Bayer, TA
    Gandy, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S223 - S224
12345